Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $8.46 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.09.
Market Cap
8.46T
Revenue
4.59T
Profits
200.89B
PE Ratio
42.09
Profit Margin
4.38%
Dividend Yield
0.43%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.00T | 4.05% | 4,595,985 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 555.59B | -0.21% | 6,803,049 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 386.27B | 1.50% | 5,189,179 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 347.39B | -0.39% | 4,254,570 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 296.11B | -0.29% | 8,944,049 | 65.77B |
| 6 | NVS | Novartis AG | 290.16B | 0.19% | 1,640,742 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 286.27B | -0.17% | 2,059,256 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 202.94B | 2.15% | 13,907,305 | 50.57B |
| 9 | AMGN | Amgen Inc. | 181.60B | 0.12% | 2,074,874 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 181.06B | 6.80% | 3,702,444 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 169.13B | 1.89% | 5,609,466 | 29.74B |
| 12 | ABT | Abbott Laboratories | 150.32B | 0.72% | 10,150,229 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 150.03B | 1.21% | 1,693,853 | 10.58B |
| 14 | PFE | Pfizer Inc. | 148.98B | -0.27% | 25,579,109 | 63.32B |
| 15 | DHR | Danaher Corporation | 127.84B | 4.33% | 5,753,576 | 24.78B |
| 16 | CVS | CVS Health Corporation | 118.62B | 0.98% | 6,900,222 | 405.62B |
| 17 | SYK | Stryker Corporation | 117.93B | 0.55% | 2,434,956 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 116.21B | -1.06% | 12,073,571 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 113.70B | 2.46% | 1,180,575 | 12.22B |
| 20 | SNY | Sanofi | 106.80B | -0.32% | 2,042,513 | 54.60B |
| 21 | GSK | GSK plc | 102.88B | -0.66% | 3,952,123 | 43.29B |
| 22 | MDT | Medtronic plc | 97.02B | -0.54% | 13,096,560 | 35.48B |
| 23 | MCK | McKesson Corporation | 90.99B | 0.07% | 871,006 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 85.29B | 0.33% | 1,346,360 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 85.27B | -1.98% | 1,595,766 | 76.39B |
| 26 | CI | The Cigna Group | 75.21B | -0.50% | 923,239 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.99B | -2.68% | 44,258,639 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.23B | -0.99% | 1,233,384 | 14.92B |
| 29 | ARGX | argenx SE | 52.11B | 2.18% | 230,094 | 4.74B |
| 30 | COR | Cencora, Inc. | 52.09B | 0.26% | 1,470,904 | 328.68B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 50.81B | - | 2,638,158 | 28.34B |
| 32 | EW | Edwards Lifesciences Corporation | 49.50B | -0.64% | 6,438,201 | 6.30B |
| 33 | MDLN | Medline Inc. | 48.34B | 2.68% | 15,283,524 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.81B | 0.01% | 1,915,994 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.81B | 3.09% | 725,830 | 4.45B |
| 36 | BDX | Becton, Dickinson and Company | 40.89B | 0.79% | 3,197,967 | 22.23B |
| 37 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.73B | 3.19% | 843,721 | 4.29B |
| 38 | HLN | Haleon plc | 40.67B | -1.18% | 5,504,115 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 40.20B | -0.12% | 3,495,820 | 17.35B |
| 40 | A | Agilent Technologies, Inc. | 38.21B | 16.87% | 6,478,093 | 7.23B |
| 41 | HUM | Humana Inc. | 37.06B | 0.79% | 576,471 | 137.20B |
| 42 | WAT | Waters Corporation | 36.00B | 7.16% | 1,441,460 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 32.87B | 1.07% | 2,650,376 | - |
| 44 | ZTS | Zoetis Inc. | 32.81B | -1.52% | 5,925,553 | 9.53B |
| 45 | ONC | BeOne Medicines AG | 32.32B | -3.10% | 314,194 | 5.70B |
| 46 | ALC | Alcon Inc. | 32.16B | -1.04% | 2,396,043 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 31.37B | 0.94% | 3,087,503 | 2.44B |
| 48 | NTRA | Natera, Inc. | 30.64B | 5.33% | 1,861,120 | 2.50B |
| 49 | IQV | IQVIA Holdings Inc. | 30.22B | 9.34% | 2,236,187 | 16.63B |
| 50 | RMD | ResMed Inc. | 29.51B | -1.30% | 1,264,504 | 5.54B |
| 51 | CNC | Centene Corporation | 29.09B | 0.15% | 3,448,114 | 178.33B |
| 52 | BIIB | Biogen Inc. | 28.99B | -0.29% | 555,946 | 9.94B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.59B | -1.60% | 4,519,920 | 20.98B |
| 54 | DXCM | DexCom, Inc. | 27.91B | 2.96% | 5,616,754 | 4.82B |
| 55 | VEEV | Veeva Systems Inc. | 26.83B | 3.72% | 1,920,488 | 3.20B |
| 56 | PHG | Koninklijke Philips N.V. | 25.44B | -0.56% | 1,186,752 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.01B | 5.68% | 2,303,574 | 4.39B |
| 58 | UTHR | United Therapeutics Corporation | 23.86B | -1.52% | 452,784 | 3.17B |
| 59 | BNTX | BioNTech SE | 23.63B | 0.47% | 914,200 | 3.23B |
| 60 | MTD | Mettler-Toledo International Inc. | 23.51B | 6.37% | 284,032 | 4.09B |
| 61 | INSM | Insmed Incorporated | 23.49B | 1.85% | 2,202,575 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.73B | 2.91% | 772,269 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.72B | 1.14% | 644,829 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 21.55B | 1.74% | 710,468 | 14.14B |
| 65 | ROIV | Roivant Sciences Ltd. | 21.49B | 1.01% | 6,291,649 | 8.26M |
| 66 | STE | STERIS plc | 21.13B | 1.19% | 844,931 | 5.94B |
| 67 | INCY | Incyte Corporation | 19.48B | 0.16% | 916,221 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 18.88B | -0.08% | 4,721,721 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.76B | -1.10% | 8,393,867 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.66B | 4.48% | 2,958,176 | 1.08B |
| 71 | GMAB | Genmab A/S | 16.27B | 1.24% | 2,323,271 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.02B | 0.31% | 2,311,314 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.73B | 0.36% | 585,512 | 3.10B |
| 74 | THC | Tenet Healthcare Corporation | 14.92B | -4.34% | 1,121,463 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.77B | -0.92% | 676,585 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 14.75B | 0.94% | 295,739 | 998.25M |
| 77 | SMMT | Summit Therapeutics Inc. | 13.51B | 0.29% | 3,963,081 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.41B | 3.03% | 1,791,899 | 579.96M |
| 79 | SOLV | Solventum Corporation | 13.15B | 0.07% | 1,554,051 | 8.26B |
| 80 | EXEL | Exelixis, Inc. | 12.93B | 2.84% | 2,707,520 | 2.38B |
| 81 | MEDP | Medpace Holdings, Inc. | 12.80B | 4.70% | 437,446 | 2.68B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 12.78B | 1.10% | 1,354,230 | 1.06B |
| 83 | SNN | Smith & Nephew plc | 12.75B | -1.46% | 974,436 | 6.16B |
| 84 | DVA | DaVita Inc. | 12.65B | 1.12% | 467,132 | 13.84B |
| 85 | PEN | Penumbra, Inc. | 12.54B | -0.43% | 462,912 | 1.45B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.51B | 0.46% | 2,248,424 | 13.65B |
| 87 | ALGN | Align Technology, Inc. | 12.41B | 6.37% | 1,584,431 | 4.10B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 11.98B | -0.72% | 469,611 | 708.24M |
| 89 | ELAN | Elanco Animal Health Incorporated | 11.98B | 1.22% | 6,423,173 | 4.89B |
| 90 | RGC | Regencell Bioscience Holdings Limited | 11.95B | 1.69% | 65,328 | - |
| 91 | COO | The Cooper Companies, Inc. | 11.91B | 0.39% | 2,156,228 | 4.15B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.88B | -2.38% | 236,948 | 1.13B |
| 93 | FMS | Fresenius Medical Care AG | 11.66B | 0.32% | 597,094 | 22.32B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.47B | -0.44% | 1,480,682 | 3.58B |
| 95 | RVTY | Revvity, Inc. | 11.29B | 4.58% | 4,081,661 | 2.90B |
| 96 | GMED | Globus Medical, Inc. | 11.19B | -0.11% | 1,412,436 | 3.10B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.13B | 0.08% | 1,016,202 | 622.01M |
| 98 | ABVX | ABIVAX Société Anonyme | 10.54B | -0.18% | 1,165,652 | 5.67M |
| 99 | ICLR | ICON Public Limited Company | 10.47B | 15.49% | 3,412,327 | 8.25B |
| 100 | EHC | Encompass Health Corporation | 10.45B | 1.03% | 688,637 | 6.07B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.43B | -0.44% | 1,971,965 | 105.82M |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.19B | 0.69% | 1,804,096 | 3.24B |
| 103 | BAX | Baxter International Inc. | 9.94B | -0.41% | 4,968,691 | 11.32B |
| 104 | ENSG | The Ensign Group, Inc. | 9.92B | -0.51% | 442,372 | 5.27B |
| 105 | PODD | Insulet Corporation | 9.88B | -2.30% | 2,676,656 | 2.90B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 9.83B | -1.26% | 222,563 | 7.46M |
| 107 | MASI | Masimo Corporation | 9.34B | -0.18% | 1,290,708 | 1.56B |
| 108 | MOH | Molina Healthcare, Inc. | 9.27B | 0.08% | 873,322 | 43.10B |
| 109 | TEM | Tempus AI, Inc. | 9.21B | 8.73% | 10,332,813 | 1.36B |
| 110 | KRYS | Krystal Biotech, Inc. | 9.15B | 1.20% | 173,864 | 417.30M |
| 111 | UHS | Universal Health Services, Inc. | 9.09B | -2.70% | 1,199,339 | 17.76B |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.73B | 10.24% | 1,300,208 | 4.03B |
| 113 | HSIC | Henry Schein, Inc. | 8.69B | 0.86% | 989,670 | 13.38B |
| 114 | NUVL | Nuvalent, Inc. | 8.63B | 1.76% | 723,095 | - |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 8.52B | 4.24% | 652,314 | 2.59B |
| 116 | BRKR | Bruker Corporation | 8.28B | 11.87% | 4,730,426 | 3.46B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.09B | -0.68% | 1,198,367 | 1.51B |
| 118 | IBRX | ImmunityBio, Inc. | 8.09B | -2.15% | 9,601,810 | 140.98M |
| 119 | TECH | Bio-Techne Corporation | 7.96B | 5.72% | 2,851,950 | 1.21B |
| 120 | HQY | HealthEquity, Inc. | 7.65B | 4.57% | 1,229,611 | 1.31B |
| 121 | QGEN | Qiagen N.V. | 7.58B | 1.41% | 2,067,660 | 2.10B |
| 122 | ATR | AptarGroup, Inc. | 7.40B | 0.60% | 509,994 | 3.87B |
| 123 | PCVX | Vaxcyte, Inc. | 7.37B | 0.08% | 1,384,758 | - |
| 124 | CORT | Corcept Therapeutics Incorporated | 7.34B | 2.60% | 1,189,732 | 769.10M |
| 125 | RGEN | Repligen Corporation | 6.92B | 8.45% | 1,584,067 | 763.34M |
| 126 | IMVT | Immunovant, Inc. | 6.88B | 0.27% | 1,884,663 | - |
| 127 | GRFS | Grifols, S.A. | 6.77B | -0.87% | 520,339 | 8.58B |
| 128 | OSCR | Oscar Health, Inc. | 6.73B | 1.55% | 4,684,080 | 13.30B |
| 129 | KYMR | Kymera Therapeutics, Inc. | 6.70B | -0.29% | 316,764 | 51.48M |
| 130 | ALKS | Alkermes plc | 6.66B | 4.86% | 2,905,645 | 1.56B |
| 131 | LNTH | Lantheus Holdings, Inc. | 6.49B | 0.53% | 873,418 | 1.55B |
| 132 | PTGX | Protagonist Therapeutics, Inc. | 6.46B | -1.76% | 462,450 | 74.06M |
| 133 | CELC | Celcuity Inc. | 6.38B | -2.28% | 903,150 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.37B | 1.71% | 549,025 | 217.17M |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.26B | -0.55% | 428,976 | - |
| 136 | GKOS | Glaukos Corporation | 6.25B | -3.06% | 1,563,826 | 551.35M |
| 137 | AVTR | Avantor, Inc. | 6.25B | 8.93% | 13,505,179 | 6.55B |
| 138 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.09% | 775,122 | 15.00M |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 6.07B | 2.31% | 536,140 | 569.61M |
| 140 | COGT | Cogent Biosciences, Inc. | 6.05B | 2.52% | 2,415,759 | - |
| 141 | PACS | PACS Group, Inc. | 6.01B | -3.06% | 584,333 | 5.43B |
| 142 | SRRK | Scholar Rock Holding Corporation | 5.97B | -1.62% | 814,331 | - |
| 143 | PTCT | PTC Therapeutics, Inc. | 5.89B | 0.55% | 725,128 | 827.11M |
| 144 | HIMS | Hims & Hers Health, Inc. | 5.87B | 0.71% | 12,873,051 | 2.37B |
| 145 | APGE | Apogee Therapeutics, Inc. | 5.83B | 0.09% | 1,124,337 | - |
| 146 | BLTE | Belite Bio, Inc | 5.82B | 4.16% | 375,717 | - |
| 147 | CHE | Chemed Corporation | 5.82B | 0.11% | 184,012 | 2.54B |
| 148 | TFX | Teleflex Incorporated | 5.74B | -0.31% | 794,136 | 2.13B |
| 149 | BLCO | Bausch + Lomb Corporation | 5.56B | -0.83% | 285,213 | 5.21B |
| 150 | LQDA | Liquidia Corporation | 5.52B | 0.01% | 837,908 | 288.07M |
| 151 | TGTX | TG Therapeutics, Inc. | 5.50B | -0.97% | 1,044,476 | 700.35M |
| 152 | CRSP | CRISPR Therapeutics AG | 5.44B | 5.32% | 2,660,907 | 4.10M |
| 153 | CGON | CG Oncology, Inc. | 5.36B | -0.12% | 688,968 | 5.07M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | 1.65% | 2,375,599 | 7.50M |
| 155 | LEGN | Legend Biotech Corporation | 5.25B | -0.84% | 1,340,967 | 1.14B |
| 156 | STVN | Stevanato Group S.p.A. | 5.09B | 3.27% | 158,467 | 1.39B |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.96B | 4.72% | 612,485 | 1.34M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.71B | 8.39% | 2,787,469 | 907.29M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 4.70B | -0.52% | 126,405 | 274.48M |
| 160 | BLLN | BillionToOne, Inc. | 4.50B | 7.45% | 684,876 | 354.54M |
| 161 | SHC | Sotera Health Company | 4.49B | 1.35% | 2,302,423 | 1.19B |
| 162 | TVTX | Travere Therapeutics, Inc. | 4.44B | - | 1,854,475 | 536.20M |
| 163 | RDNT | RadNet, Inc. | 4.35B | 2.73% | 476,951 | 2.14B |
| 164 | TWST | Twist Bioscience Corporation | 4.30B | 7.57% | 2,259,710 | 409.48M |
| 165 | MANE | Veradermics, Incorporated | 4.30B | 2.75% | 482,164 | - |
| 166 | HNGE | Hinge Health, Inc. | 4.25B | 2.56% | 1,240,962 | 646.34M |
| 167 | NAMS | NewAmsterdam Pharma Company N.V. | 4.14B | -3.12% | 776,274 | 22.57M |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 4.13B | 1.33% | 2,006,534 | 3.05B |
| 169 | LIVN | LivaNova PLC | 4.01B | -1.16% | 758,890 | 1.43B |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.91B | -1.93% | 482,840 | 754.05M |
| 171 | DOCS | Doximity, Inc. | 3.85B | 4.00% | 4,286,737 | 644.86M |
| 172 | NVST | Envista Holdings Corporation | 3.85B | 1.54% | 2,260,454 | 2.81B |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | -0.10% | 2,208,662 | 596.96M |
| 174 | VCYT | Veracyte, Inc. | 3.83B | 7.87% | 999,299 | 541.74M |
| 175 | MMSI | Merit Medical Systems, Inc. | 3.80B | 1.97% | 630,255 | 1.54B |
| 176 | IRTC | iRhythm Holdings, Inc. | 3.80B | 3.79% | 674,530 | 787.85M |
| 177 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.80B | -2.12% | 801,987 | 18.07M |
| 178 | ERAS | Erasca, Inc. | 3.79B | -2.17% | 3,972,806 | - |
| 179 | VKTX | Viking Therapeutics, Inc. | 3.74B | 1.67% | 1,456,124 | - |
| 180 | WAY | Waystar Holding Corp. | 3.72B | 1.73% | 2,009,841 | 1.16B |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | 2.08% | 1,075,588 | 1.10B |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.57B | -1.19% | 1,529,765 | - |
| 183 | TXG | 10x Genomics, Inc. | 3.55B | 9.72% | 3,069,046 | 638.78M |
| 184 | OGN | Organon & Co. | 3.51B | -0.22% | 2,647,915 | 6.16B |
| 185 | ORKA | Oruka Therapeutics, Inc. | 3.50B | -0.02% | 617,977 | - |
| 186 | ICUI | ICU Medical, Inc. | 3.47B | 0.38% | 480,336 | 2.16B |
| 187 | OPCH | Option Care Health, Inc. | 3.39B | -0.28% | 2,774,124 | 5.67B |
| 188 | DNLI | Denali Therapeutics Inc. | 3.32B | 3.66% | 1,119,428 | - |
| 189 | ALHC | Alignment Healthcare, Inc. | 3.28B | -0.41% | 3,676,852 | 4.26B |
| 190 | BEAM | Beam Therapeutics Inc. | 3.26B | 2.85% | 1,797,808 | 164.01M |
| 191 | CON | Concentra Group Holdings Parent, Inc. | 3.25B | -1.71% | 691,973 | 2.23B |
| 192 | MMED | MiniMed Group, Inc. | 3.23B | 6.57% | 569,910 | 2.99B |
| 193 | GRAL | GRAIL, Inc. | 3.19B | 4.21% | 1,079,263 | 156.12M |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.17B | -2.16% | 95,172 | 803.79M |
| 195 | WRBY | Warby Parker Inc. | 3.16B | 0.16% | 1,523,303 | 890.57M |
| 196 | BKD | Brookdale Senior Living Inc. | 3.11B | -3.48% | 2,492,111 | 3.00B |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.08B | 2.13% | 715,905 | 236.00M |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.07B | 2.20% | 749,294 | - |
| 199 | ITGR | Integer Holdings Corporation | 3.06B | 1.21% | 611,400 | 1.86B |
| 200 | HAE | Haemonetics Corporation | 3.05B | -0.18% | 1,014,291 | 1.33B |
| 201 | RLAY | Relay Therapeutics, Inc. | 3.03B | -3.67% | 2,541,455 | 10.68M |
| 202 | LFST | LifeStance Health Group, Inc. | 3.03B | 2.63% | 2,201,119 | 1.49B |
| 203 | KLRA | Kailera Therapeutics, Inc. | 2.97B | 4.70% | 397,076 | - |
| 204 | TNGX | Tango Therapeutics, Inc. | 2.89B | 1.78% | 2,374,963 | 56.99M |
| 205 | NHC | National HealthCare Corporation | 2.89B | -3.73% | 86,117 | 1.53B |
| 206 | GPCR | Structure Therapeutics Inc. | 2.85B | 1.59% | 284,341 | - |
| 207 | GMRS | GMR Solutions Inc. | 2.79B | 5.56% | 692,737 | 5.74B |
| 208 | HTFL | HeartFlow, Inc. | 2.73B | 8.27% | 1,343,872 | 191.42M |
| 209 | ALMS | Alumis Inc. | 2.73B | 0.33% | 365,098 | 8.40M |
| 210 | PRVA | Privia Health Group, Inc. | 2.72B | -0.69% | 771,108 | 2.25B |
| 211 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | 0.45% | 635,590 | 776.83M |
| 212 | IRON | Disc Medicine, Inc. | 2.70B | 1.49% | 420,766 | - |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 2.68B | 1.37% | 775,948 | 415.62M |
| 214 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | 5.10% | 1,288,911 | - |
| 215 | IDYA | IDEAYA Biosciences, Inc. | 2.58B | 0.20% | 432,793 | 225.27M |
| 216 | VERA | Vera Therapeutics, Inc. | 2.57B | 4.64% | 1,717,022 | - |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.56B | -0.87% | 279,195 | 535.08M |
| 218 | DFTX | Definium Therapeutics, Inc. | 2.56B | -0.17% | 3,157,658 | - |
| 219 | IMNM | Immunome, Inc. | 2.55B | 1.94% | 501,260 | 4.02M |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.49B | 0.16% | 727,137 | 865.00K |
| 221 | ELVN | Enliven Therapeutics, Inc. | 2.48B | -1.84% | 303,292 | - |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.45B | -0.95% | 361,364 | 1.46B |
| 223 | ADPT | Adaptive Biotechnologies Corporation | 2.43B | 9.75% | 1,578,884 | 295.41M |
| 224 | TMDX | TransMedics Group, Inc. | 2.34B | -3.31% | 1,596,525 | 635.89M |
| 225 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.31B | -0.22% | 3,315,237 | 885.72M |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.30B | 0.41% | 486,234 | 1.09B |
| 227 | RARE | Ultragenyx Pharmaceutical Inc. | 2.28B | -0.56% | 1,257,225 | 670.00M |
| 228 | KOD | Kodiak Sciences Inc. | 2.26B | 2.94% | 463,660 | - |
| 229 | CLOV | Clover Health Investments, Corp. | 2.20B | 16.43% | 20,713,497 | 2.21B |
| 230 | NKTR | Nektar Therapeutics | 2.20B | -0.60% | 588,703 | 55.63M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.19B | -1.37% | 1,249,784 | 3.37B |
| 232 | LMAT | LeMaitre Vascular, Inc. | 2.16B | -1.23% | 216,705 | 256.28M |
| 233 | AXGN | Axogen, Inc. | 2.15B | 1.38% | 775,467 | 238.11M |
| 234 | ESTA | Establishment Labs Holdings Inc. | 2.15B | 2.33% | 297,525 | 229.58M |
| 235 | ZLAB | Zai Lab Limited | 2.08B | -0.94% | 959,392 | 453.28M |
| 236 | PHVS | Pharvaris N.V. | 2.08B | 1.32% | 254,980 | - |
| 237 | HCM | HUTCHMED (China) Limited | 2.08B | -4.18% | 61,975 | 548.51M |
| 238 | XRAY | DENTSPLY SIRONA Inc. | 2.06B | 2.90% | 13,538,063 | 3.68B |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.05B | - | 922,514 | - |
| 240 | SEM | Select Medical Holdings Corporation | 2.05B | - | 1,266,125 | 5.52B |
| 241 | OMCL | Omnicell, Inc. | 2.03B | 3.71% | 297,021 | 1.23B |
| 242 | NEOG | Neogen Corporation | 2.02B | 1.09% | 2,985,887 | 870.56M |
| 243 | BHC | Bausch Health Companies Inc. | 2.02B | 0.37% | 1,524,004 | 10.53B |
| 244 | NBTX | Nanobiotix S.A. | 2.01B | -0.93% | 17,698 | 38.27M |
| 245 | PGNY | Progyny, Inc. | 2.01B | 0.82% | 1,017,224 | 1.29B |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.00B | 7.14% | 3,382,647 | 52.04M |
| 247 | NVCR | NovoCure Limited | 2.00B | 1.53% | 1,169,527 | 674.41M |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -1.22% | 598,092 | 298.30M |
| 249 | STOK | Stoke Therapeutics, Inc. | 1.97B | 0.48% | 382,895 | 32.08M |
| 250 | TYRA | Tyra Biosciences, Inc. | 1.94B | -1.48% | 494,770 | - |
| 251 | SION | Sionna Therapeutics, Inc. | 1.93B | -1.45% | 416,031 | - |
| 252 | VRDN | Viridian Therapeutics, Inc. | 1.93B | 1.10% | 875,911 | 70.92M |
| 253 | IOVA | Iovance Biotherapeutics, Inc. | 1.92B | -1.60% | 8,333,739 | 285.61M |
| 254 | NTLA | Intellia Therapeutics, Inc. | 1.91B | 1.79% | 4,520,462 | 66.09M |
| 255 | ASTH | Astrana Health, Inc. | 1.90B | -0.49% | 320,344 | 3.53B |
| 256 | RAPP | Rapport Therapeutics, Inc. | 1.89B | -0.05% | 187,740 | 20.00M |
| 257 | MESO | Mesoblast Limited | 1.88B | 0.68% | 78,835 | 65.38M |
| 258 | ZYME | Zymeworks Inc. | 1.86B | 2.78% | 389,920 | 81.26M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 2.20% | 93,241 | 1.20B |
| 260 | ADMA | ADMA Biologics, Inc. | 1.84B | 0.13% | 2,224,438 | 509.86M |
| 261 | NRIX | Nurix Therapeutics, Inc. | 1.83B | 1.14% | 866,256 | 71.78M |
| 262 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | 3.72% | 2,928,815 | 2.18B |
| 263 | RXRX | Recursion Pharmaceuticals, Inc. | 1.83B | 8.52% | 24,391,953 | 66.41M |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 1.83B | 2.52% | 894,260 | 899.11M |
| 265 | AGIO | Agios Pharmaceuticals, Inc. | 1.81B | 6.29% | 987,582 | 66.05M |
| 266 | SGRY | Surgery Partners, Inc. | 1.77B | 1.26% | 971,849 | 3.34B |
| 267 | UFPT | UFP Technologies, Inc. | 1.76B | 0.72% | 114,005 | 608.85M |
| 268 | AAPG | Ascentage Pharma Group International | 1.76B | -4.88% | 24,001 | 82.08M |
| 269 | OCS | Oculis Holding AG | 1.75B | 0.14% | 307,408 | 1.51M |
| 270 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | 0.71% | 1,010,907 | 217.17M |
| 271 | ABCL | AbCellera Biologics Inc. | 1.75B | 5.33% | 7,352,538 | 79.21M |
| 272 | VCEL | Vericel Corporation | 1.75B | -0.09% | 397,009 | 292.09M |
| 273 | MD | Pediatrix Medical Group, Inc. | 1.73B | -0.18% | 553,072 | 1.93B |
| 274 | ANIP | ANI Pharmaceuticals, Inc. | 1.72B | -0.80% | 174,062 | 923.71M |
| 275 | PLSE | Pulse Biosciences, Inc. | 1.71B | 0.08% | 243,260 | 751.00K |
| 276 | ADUS | Addus HomeCare Corporation | 1.71B | -0.52% | 189,068 | 1.45B |
| 277 | SLS | SELLAS Life Sciences Group, Inc. | 1.71B | 6.99% | 10,140,337 | - |
| 278 | TSHA | Taysha Gene Therapies, Inc. | 1.70B | 2.96% | 2,085,258 | 7.47M |
| 279 | NVAX | Novavax, Inc. | 1.70B | -6.94% | 6,968,759 | 596.34M |
| 280 | CAPR | Capricor Therapeutics, Inc. | 1.69B | -0.10% | 363,055 | 11.13M |
| 281 | SNDA | Sonida Senior Living, Inc. | 1.68B | -2.91% | 465,257 | 367.34M |
| 282 | GENB | Generate Biomedicines, Inc. | 1.68B | 0.08% | 417,844 | 30.30M |
| 283 | PVLA | Palvella Therapeutics, Inc. | 1.66B | -0.34% | 114,568 | - |
| 284 | ANAB | AnaptysBio, Inc. | 1.66B | -1.16% | 619,758 | 232.39M |
| 285 | NUVB | Nuvation Bio Inc. | 1.65B | 0.21% | 1,435,690 | 143.05M |
| 286 | GLUE | Monte Rosa Therapeutics, Inc. | 1.64B | 1.15% | 879,040 | 42.95M |
| 287 | ATAI | AtaiBeckley Inc. | 1.62B | 2.08% | 4,103,017 | 3.49M |
| 288 | INVA | Innoviva, Inc. | 1.62B | -1.08% | 770,739 | 420.69M |
| 289 | VIR | Vir Biotechnology, Inc. | 1.61B | 4.95% | 2,309,789 | 65.50M |
| 290 | CMPS | COMPASS Pathways plc | 1.61B | 0.59% | 2,555,362 | - |
| 291 | PGEN | Precigen, Inc. | 1.61B | 2.50% | 5,239,318 | 31.60M |
| 292 | AVAH | Aveanna Healthcare Holdings Inc. | 1.60B | -0.14% | 896,656 | 2.52B |
| 293 | PRGO | Perrigo Company plc | 1.58B | 2.51% | 2,366,418 | 4.18B |
| 294 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.58B | 1.07% | 477,250 | -665.00K |
| 295 | QURE | uniQure N.V. | 1.57B | -1.27% | 585,837 | 18.09M |
| 296 | PRCT | PROCEPT BioRobotics Corporation | 1.55B | 2.80% | 1,147,724 | 322.02M |
| 297 | ARDX | Ardelyx, Inc. | 1.54B | 1.30% | 1,979,422 | 427.68M |
| 298 | BHVN | Biohaven Ltd. | 1.54B | -9.30% | 4,079,950 | - |
| 299 | IMTX | Immatics N.V. | 1.54B | 0.61% | 133,186 | 43.00M |
| 300 | GHRS | GH Research PLC | 1.54B | 0.09% | 102,839 | - |
| 301 | DMRA | Damora Therapeutics, Inc. | 1.53B | -1.47% | 281,239 | - |
| 302 | INBX | Inhibrx Biosciences, Inc. | 1.53B | 0.95% | 369,188 | 1.30M |
| 303 | MBX | MBX Biosciences, Inc. | 1.52B | 0.06% | 377,275 | - |
| 304 | NNNN | Anbio Biotechnology | 1.51B | 5.03% | 18,249 | 8.65M |
| 305 | AGL | agilon health, inc. | 1.51B | 0.16% | 181,296 | 5.82B |
| 306 | WGS | GeneDx Holdings Corp. | 1.49B | 4.02% | 1,233,407 | 442.68M |
| 307 | IMCR | Immunocore Holdings plc | 1.47B | 1.58% | 654,576 | 412.81M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.46B | 1.34% | 178,898 | 20.00M |
| 309 | STAA | STAAR Surgical Company | 1.45B | -7.36% | 1,374,063 | 290.38M |
| 310 | BCAX | Bicara Therapeutics Inc. | 1.43B | 0.79% | 699,090 | - |
| 311 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | -0.07% | 918,179 | 114.48M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.42B | 0.63% | 470,832 | 1.85B |
| 313 | ATRC | AtriCure, Inc. | 1.42B | 2.33% | 1,122,742 | 552.16M |
| 314 | FTRE | Fortrea Holdings Inc. | 1.42B | 11.77% | 1,331,816 | 2.71B |
| 315 | SEPN | Septerna, Inc. | 1.40B | 4.23% | 219,143 | 72.26M |
| 316 | URGN | UroGen Pharma Ltd. | 1.40B | -2.18% | 365,218 | 140.49M |
| 317 | AHCO | AdaptHealth Corp. | 1.38B | -0.10% | 1,185,819 | 3.29B |
| 318 | ALMR | Alamar Biosciences, Inc. | 1.37B | 3.35% | 171,791 | 87.16M |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.36B | 1.47% | 566,632 | - |
| 320 | ARDT | Ardent Health, Inc. | 1.36B | 0.64% | 289,570 | 6.43B |
| 321 | TDOC | Teladoc Health, Inc. | 1.36B | 13.96% | 8,001,940 | 2.51B |
| 322 | MPLT | MapLight Therapeutics, Inc. | 1.35B | 0.78% | 485,683 | - |
| 323 | NEO | NeoGenomics, Inc. | 1.33B | 6.48% | 1,628,597 | 745.97M |
| 324 | ENOV | Enovis Corporation | 1.33B | -0.30% | 1,118,555 | 2.28B |
| 325 | AHG | Akso Health Group | 1.32B | -1.28% | 2,602 | 14.84M |
| 326 | HROW | Harrow, Inc. | 1.32B | 2.79% | 583,581 | 268.68M |
| 327 | PAHC | Phibro Animal Health Corporation | 1.29B | -3.22% | 322,732 | 1.50B |
| 328 | SVRA | Savara Inc. | 1.29B | -2.30% | 2,937,434 | - |
| 329 | IART | Integra LifeSciences Holdings Corporation | 1.28B | 8.36% | 1,340,893 | 1.64B |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.26B | -1.82% | 408,668 | - |
| 331 | WVE | Wave Life Sciences Ltd. | 1.24B | 2.05% | 3,044,316 | 71.80M |
| 332 | COAG | Hemab Therapeutics Holdings, Inc. | 1.24B | -1.56% | 132,989 | - |
| 333 | INSP | Inspire Medical Systems, Inc. | 1.24B | 2.01% | 921,734 | 915.25M |
| 334 | KMTS | Kestra Medical Technologies, Ltd. | 1.24B | 1.19% | 206,384 | 83.72M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.23B | 3.06% | 440,052 | 101.66M |
| 336 | ATEC | Alphatec Holdings, Inc. | 1.21B | 0.77% | 2,659,760 | 787.08M |
| 337 | BFLY | Butterfly Network, Inc. | 1.21B | -1.50% | 2,276,035 | 102.92M |
| 338 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.20B | 6.18% | 2,101,045 | 204.73M |
| 339 | PNTG | The Pennant Group, Inc. | 1.19B | 1.06% | 183,981 | 1.02B |
| 340 | AVLN | Avalyn Pharma Inc. | 1.19B | 5.85% | 394,971 | - |
| 341 | IRMD | IRADIMED CORPORATION | 1.18B | 0.38% | 74,626 | 86.28M |
| 342 | CDNA | CareDx, Inc. | 1.17B | 2.44% | 772,886 | 412.82M |
| 343 | ZBIO | Zenas BioPharma, Inc. | 1.17B | 2.60% | 733,709 | 10.00M |
| 344 | AVNS | Avanos Medical, Inc. | 1.16B | -0.12% | 643,705 | 715.90M |
| 345 | PSNL | Personalis, Inc. | 1.15B | 15.70% | 4,091,984 | 64.52M |
| 346 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 12.82% | 3,611,228 | 1.03B |
| 347 | EYPT | EyePoint, Inc. | 1.13B | 2.58% | 1,435,499 | 7.61M |
| 348 | AKTS | Aktis Oncology, Inc. | 1.13B | 2.56% | 99,602 | 8.28M |
| 349 | MNKD | MannKind Corporation | 1.12B | 2.54% | 4,917,040 | 360.78M |
| 350 | OLMA | Olema Pharmaceuticals, Inc. | 1.11B | -1.16% | 1,157,308 | - |
| 351 | DBVT | DBV Technologies S.A. | 1.11B | 2.65% | 420,259 | 5.74M |
| 352 | IVA | Inventiva S.A. | 1.11B | 0.19% | 135,891 | 7.94M |
| 353 | AORT | Artivion, Inc. | 1.10B | -0.83% | 437,877 | 458.69M |
| 354 | XERS | Xeris Biopharma Holdings, Inc. | 1.09B | 1.44% | 1,662,703 | 314.85M |
| 355 | AMN | AMN Healthcare Services, Inc. | 1.08B | 2.68% | 718,141 | 3.42B |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.08B | -0.92% | 250,288 | 796.33M |
| 357 | OPK | OPKO Health, Inc. | 1.08B | 10.00% | 5,421,370 | 581.12M |
| 358 | ALVO | Alvotech | 1.07B | -0.29% | 401,722 | 562.04M |
| 359 | CNMD | CONMED Corporation | 1.07B | 0.11% | 346,839 | 1.37B |
| 360 | OMDA | Omada Health, Inc. | 1.06B | 8.26% | 1,578,139 | 283.30M |
| 361 | SDGR | Schrödinger, Inc. | 1.06B | 6.95% | 1,106,234 | 254.91M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.05B | -3.33% | 1,622,313 | - |
| 363 | AZTA | Azenta, Inc. | 1.04B | 5.39% | 1,837,462 | 596.48M |
| 364 | JBIO | Jade Biosciences, Inc. | 1.03B | -3.07% | 493,815 | - |
| 365 | EVO | Evotec SE | 1.03B | 3.14% | 23,502 | 859.03M |
| 366 | INNV | InnovAge Holding Corp. | 1.02B | 1.08% | 150,679 | 949.17M |
| 367 | CRON | Cronos Group Inc. | 1.01B | 4.41% | 1,783,811 | 159.54M |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.01B | 3.85% | 1,904,469 | 787.89M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 996.92M | 4.16% | 316,680 | - |
| 370 | LXRX | Lexicon Pharmaceuticals, Inc. | 981.47M | 1.84% | 1,861,250 | 69.64M |
| 371 | USPH | U.S. Physical Therapy, Inc. | 972.33M | -0.44% | 199,664 | 787.69M |
| 372 | PHAR | Pharming Group N.V. | 971.60M | 0.52% | 11,998 | 369.49M |
| 373 | ABSI | Absci Corporation | 947.90M | 17.83% | 7,691,517 | 1.84M |
| 374 | CGEM | Cullinan Therapeutics, Inc. | 944.00M | -1.03% | 792,971 | - |
| 375 | SPRY | ARS Pharmaceuticals, Inc. | 933.45M | 10.59% | 2,349,494 | 98.99M |
| 376 | PCRX | Pacira BioSciences, Inc. | 931.76M | -1.50% | 242,874 | 734.86M |
| 377 | MGTX | MeiraGTx Holdings plc | 926.10M | 1.11% | 704,289 | 79.76M |
| 378 | DRTS | Alpha Tau Medical Ltd. | 913.48M | -1.55% | 904,365 | - |
| 379 | ABUS | Arbutus Biopharma Corporation | 908.67M | -0.86% | 888,656 | 191.45M |
| 380 | NUTX | Nutex Health Inc. | 903.18M | 9.88% | 199,805 | 879.95M |
| 381 | JANX | Janux Therapeutics, Inc. | 898.91M | 2.08% | 1,010,441 | 13.73M |
| 382 | QDEL | QuidelOrtho Corporation | 891.26M | 6.00% | 1,759,521 | 2.66B |
| 383 | INMD | InMode Ltd. | 890.19M | 1.74% | 717,049 | 374.64M |
| 384 | XNCR | Xencor, Inc. | 887.47M | 2.13% | 283,639 | 97.36M |
| 385 | KURA | Kura Oncology, Inc. | 885.08M | -2.64% | 1,604,451 | 71.64M |
| 386 | CERT | Certara, Inc. | 882.05M | 5.98% | 2,616,868 | 419.75M |
| 387 | ANNX | Annexon, Inc. | 879.83M | -0.37% | 2,720,163 | - |
| 388 | ORIC | ORIC Pharmaceuticals, Inc. | 874.72M | -1.52% | 964,652 | - |
| 389 | ETON | Eton Pharmaceuticals, Inc. | 872.72M | -1.67% | 395,345 | 86.93M |
| 390 | DRUG | Bright Minds Biosciences Inc. | 872.67M | 2.81% | 263,808 | - |
| 391 | SANA | Sana Biotechnology, Inc. | 871.05M | 2.29% | 6,172,545 | - |
| 392 | TALK | Talkspace, Inc. | 869.39M | -0.19% | 1,198,118 | 238.37M |
| 393 | AMPH | Amphastar Pharmaceuticals, Inc. | 850.99M | 1.05% | 621,213 | 720.53M |
| 394 | AVTX | Avalo Therapeutics, Inc. | 847.88M | 2.15% | 1,672,361 | 59.00K |
| 395 | ODTX | Odyssey Therapeutics, Inc. | 845.36M | 4.25% | 307,057 | 2.98M |
| 396 | EVMN | Evommune, Inc. | 840.31M | -0.04% | 413,107 | 10.00M |
| 397 | TBPH | Theravance Biopharma, Inc. | 835.67M | -0.31% | 358,584 | 109.78M |
| 398 | AVR | Anteris Technologies Global Corp. | 834.88M | -1.02% | 867,153 | 1.85M |
| 399 | AURA | Aura Biosciences, Inc. | 827.25M | -2.09% | 339,758 | - |
| 400 | PHAT | Phathom Pharmaceuticals, Inc. | 819.72M | -3.91% | 1,407,496 | 204.89M |
| 401 | VOR | Vor Biopharma Inc. | 813.33M | -3.29% | 627,603 | - |
| 402 | CTMX | CytomX Therapeutics, Inc. | 807.68M | -2.62% | 2,139,822 | 35.54M |
| 403 | OMER | Omeros Corporation | 806.99M | 0.72% | 1,192,886 | 9.89M |
| 404 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 5,627,600 | 418.24M |
| 405 | GERN | Geron Corporation | 801.90M | -0.79% | 9,493,093 | 196.12M |
| 406 | LBRX | LB Pharmaceuticals Inc | 789.47M | -0.97% | 109,038 | - |
| 407 | SSII | SS Innovations International, Inc. | 787.76M | 4.79% | 63,140 | 48.47M |
| 408 | ALLO | Allogene Therapeutics, Inc. | 776.60M | - | 6,508,503 | 22.00K |
| 409 | RLMD | Relmada Therapeutics, Inc. | 760.44M | -0.14% | 501,331 | - |
| 410 | BIOA | BioAge Labs, Inc. | 757.92M | 0.59% | 230,613 | 10.32M |
| 411 | BVS | Bioventus Inc. | 741.79M | -0.22% | 506,096 | 576.30M |
| 412 | LMRI | Lumexa Imaging Holdings, Inc. | 739.82M | -0.26% | 625,212 | 1.03B |
| 413 | HSTM | HealthStream, Inc. | 719.57M | 1.57% | 303,618 | 311.78M |
| 414 | CBIO | Crescent Biopharma, Inc. | 713.43M | 3.27% | 401,101 | 11.88M |
| 415 | ANRO | Alto Neuroscience, Inc. | 708.77M | -1.08% | 247,151 | - |
| 416 | CBLL | CeriBell, Inc. | 708.39M | -0.16% | 159,568 | 95.07M |
| 417 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.15M | 3.63% | 124,317 | - |
| 418 | SLDB | Solid Biosciences Inc. | 696.04M | 0.71% | 727,868 | - |
| 419 | TENX | Tenax Therapeutics, Inc. | 688.29M | -1.60% | 624,091 | - |
| 420 | TLRY | Tilray Brands, Inc. | 673.95M | 1.80% | 4,337,572 | 858.28M |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 673.91M | 4.11% | 3,072,509 | 122.29M |
| 422 | DSGN | Design Therapeutics, Inc. | 670.79M | -3.24% | 625,197 | - |
| 423 | CSTL | Castle Biosciences, Inc. | 670.60M | 4.00% | 297,164 | 339.92M |
| 424 | SGP | SpyGlass Pharma, Inc. | 665.19M | -1.34% | 41,434 | - |
| 425 | CRMD | CorMedix Inc. | 660.56M | -0.47% | 1,287,137 | 400.05M |
| 426 | SIBN | SI-BONE, Inc. | 639.07M | -0.35% | 401,087 | 206.22M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 638.26M | -0.22% | 640,780 | 8.37M |
| 428 | BWAY | BrainsWay Ltd. | 633.64M | 2.06% | 128,370 | 56.22M |
| 429 | IMMX | Immix Biopharma, Inc. | 623.93M | 2.41% | 1,178,139 | - |
| 430 | DNA | Ginkgo Bioworks Holdings, Inc. | 617.97M | 8.61% | 1,334,457 | 151.40M |
| 431 | CABA | Cabaletta Bio, Inc. | 614.72M | -1.57% | 2,527,036 | - |
| 432 | PRME | Prime Medicine, Inc. | 614.10M | 3.03% | 2,063,044 | 4.03M |
| 433 | ALT | Altimmune, Inc. | 597.04M | 3.02% | 3,913,431 | 36.00K |
| 434 | NPCE | NeuroPace, Inc. | 592.89M | 1.93% | 99,396 | 99.53M |
| 435 | CADL | Candel Therapeutics, Inc. | 592.76M | 0.50% | 1,385,359 | - |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 592.61M | -2.96% | 1,879,405 | 361.51M |
| 437 | VALN | Valneva SE | 590.53M | -0.63% | 22,029 | 180.25M |
| 438 | CERS | Cerus Corporation | 585.08M | 3.55% | 3,522,934 | 216.56M |
| 439 | PHR | Phreesia, Inc. | 583.77M | 3.50% | 5,541,851 | 495.59M |
| 440 | TCMD | Tactile Systems Technology, Inc. | 576.31M | 1.91% | 285,187 | 343.52M |
| 441 | ARVN | Arvinas, Inc. | 570.37M | -0.11% | 509,476 | 89.40M |
| 442 | AGMB | AgomAb Therapeutics NV | 568.32M | -1.11% | 36,527 | - |
| 443 | TECX | Tectonic Therapeutic, Inc. | 563.43M | -1.87% | 89,126 | - |
| 444 | SRTA | Strata Critical Medical, Inc. | 559.83M | 3.35% | 895,145 | 228.58M |
| 445 | EIKN | Eikon Therapeutics, Inc. | 557.63M | -0.68% | 696,240 | - |
| 446 | RIGL | Rigel Pharmaceuticals, Inc. | 555.99M | 1.93% | 299,182 | 299.77M |
| 447 | TRAX | First Tracks Biotherapeutics, Inc. | 552.00M | -1.98% | 281,921 | - |
| 448 | ASMB | Assembly Biosciences, Inc. | 549.53M | 1.20% | 108,464 | 71.10M |
| 449 | PROK | ProKidney Corp. | 546.73M | - | 1,098,272 | 889.00K |
| 450 | MDXG | MiMedx Group, Inc. | 546.63M | 1.66% | 1,188,726 | 389.42M |
| 451 | ACHV | Achieve Life Sciences, Inc. | 544.09M | 10.88% | 2,268,014 | - |
| 452 | CLYM | Climb Bio, Inc. | 541.70M | -5.18% | 886,628 | - |
| 453 | BBNX | Beta Bionics, Inc. | 539.20M | 4.04% | 580,182 | 110.24M |
| 454 | CTKB | Cytek Biosciences, Inc. | 532.07M | 3.26% | 887,291 | 204.17M |
| 455 | EDIT | Editas Medicine, Inc. | 526.37M | -3.92% | 4,784,041 | 38.69M |
| 456 | KYTX | Kyverna Therapeutics, Inc. | 523.59M | 0.70% | 777,009 | - |
| 457 | GYRE | Gyre Therapeutics, Inc. | 523.56M | -3.21% | 96,255 | 117.05M |
| 458 | XOMA | XOMA Royalty Corporation | 522.96M | -0.10% | 244,457 | 48.56M |
| 459 | PRTA | Prothena Corporation plc | 522.49M | -0.50% | 235,341 | 57.94M |
| 460 | FLGT | Fulgent Genetics, Inc. | 518.03M | 1.90% | 478,190 | 320.35M |
| 461 | FBRX | Forte Biosciences, Inc. | 514.61M | -1.91% | 144,897 | - |
| 462 | AQST | Aquestive Therapeutics, Inc. | 504.31M | 0.50% | 1,350,408 | 50.27M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 464 | CTNM | Contineum Therapeutics, Inc. | 500.04M | -0.48% | 91,644 | - |
| 465 | ANGO | AngioDynamics, Inc. | 491.43M | -0.42% | 328,220 | 313.73M |
| 466 | STRO | Sutro Biopharma, Inc. | 490.91M | -0.20% | 188,732 | 102.48M |
| 467 | OCGN | Ocugen, Inc. | 477.32M | 2.17% | 4,420,276 | 4.47M |
| 468 | EBS | Emergent BioSolutions Inc. | 473.65M | 2.00% | 878,809 | 676.80M |
| 469 | TOI | The Oncology Institute, Inc. | 470.92M | 2.17% | 1,322,626 | 545.76M |
| 470 | FDMT | 4D Molecular Therapeutics, Inc. | 468.92M | 1.36% | 276,991 | 88.24M |
| 471 | EPRX | Eupraxia Pharmaceuticals Inc. | 468.45M | 2.51% | 118,375 | - |
| 472 | AUTL | Autolus Therapeutics plc | 467.08M | 4.46% | 1,593,216 | 92.62M |
| 473 | CATX | Perspective Therapeutics, Inc. | 461.89M | -2.64% | 1,254,775 | 618.00K |
| 474 | STTK | Shattuck Labs, Inc. | 458.93M | -1.24% | 321,397 | 1.00M |
| 475 | WEAV | Weave Communications, Inc. | 458.30M | 3.23% | 780,853 | 248.72M |
| 476 | KIDS | OrthoPediatrics Corp. | 457.45M | 1.48% | 75,976 | 243.30M |
| 477 | OVID | Ovid Therapeutics Inc. | 456.82M | 3.94% | 1,745,097 | 7.12M |
| 478 | PACB | Pacific Biosciences of California, Inc. | 456.58M | 13.95% | 8,725,791 | 160.03M |
| 479 | FULC | Fulcrum Therapeutics, Inc. | 454.44M | 0.59% | 313,646 | 80.00M |
| 480 | KMDA | Kamada Ltd. | 453.16M | -1.50% | 26,190 | 181.68M |
| 481 | UPB | Upstream Bio, Inc. | 452.77M | 0.73% | 320,803 | 3.32M |
| 482 | ANL | Adlai Nortye Ltd. | 452.00M | 2.73% | 85,726 | 5.00M |
| 483 | SGMT | Sagimet Biosciences Inc. | 448.94M | 0.69% | 645,927 | - |
| 484 | LAB | Standard BioTools Inc. | 445.02M | 7.55% | 2,174,148 | 86.26M |
| 485 | VREX | Varex Imaging Corporation | 443.38M | 3.04% | 362,285 | 857.50M |
| 486 | NRC | NRC Health | 443.07M | 2.77% | 140,293 | 138.64M |
| 487 | ADCT | ADC Therapeutics SA | 438.81M | 0.58% | 454,431 | 79.18M |
| 488 | EVH | Evolent Health, Inc. | 438.68M | 4.84% | 2,258,936 | 1.89B |
| 489 | NGNE | Neurogene Inc. | 434.55M | 2.34% | 62,147 | 925.00K |
| 490 | CMPX | Compass Therapeutics, Inc. | 434.01M | 6.17% | 4,578,806 | 850.00K |
| 491 | EOLS | Evolus, Inc. | 432.67M | 6.31% | 976,693 | 301.79M |
| 492 | MNPR | Monopar Therapeutics Inc. | 431.70M | -0.16% | 113,685 | - |
| 493 | MOBI | Mobia Medical, Inc. | 431.43M | 0.46% | 64,268 | 32.04M |
| 494 | IPSC | Century Therapeutics, Inc. | 430.14M | 3.47% | 1,108,315 | 109.16M |
| 495 | CTEV | Claritev Corporation | 418.69M | 6.46% | 72,746 | 978.76M |
| 496 | VTVT | vTv Therapeutics Inc. | 415.72M | -0.65% | 28,804 | 36.84M |
| 497 | CGC | Canopy Growth Corporation | 410.17M | 4.67% | 8,377,841 | 203.04M |
| 498 | CCRN | Cross Country Healthcare, Inc. | 405.90M | 0.15% | 162,512 | 1.00B |
| 499 | CCCC | C4 Therapeutics, Inc. | 403.26M | -2.14% | 1,038,610 | 34.86M |
| 500 | GLSI | Greenwich LifeSciences, Inc. | 401.64M | -0.82% | 104,911 | - |